[Evaluation of the effectiveness of anti-ulcer preparations (dalargin, gastrocepin, solcoseryl) in the ambulatory treatment of peptic ulcer].
Bulgakov
S A
SA
El'bov
P V
PV
Vinogradov
V A
VA
D000183:Actihaemyl / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000553:Ambulatory Care; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004743:Enkephalin, Leucine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016308:Enkephalin, Leucine-2-Alanine / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010276:Parasympatholytics / Q000627:therapeutic use; D010437:Peptic Ulcer / Q000188:drug therapy*; D014020:Tissue Extracts / Q000627:therapeutic use*
D000897:Anti-Ulcer Agents; D010276:Parasympatholytics; D014020:Tissue Extracts; D000183:Actihaemyl; D004743:Enkephalin, Leucine; D016308:Enkephalin, Leucine-2-Alanine; C040996:enkephalin-Leu, Ala(2)-Arg(6)-
Otsenka éffektivnosti protivoiazvennykh preparatov (dalargina, gastrotsepina, solkoserina) v lechenii iazvennoĭ bolezni v ambulatornykh usloviiakh.